Prospective Phase II Study of Neoadjuvant Therapy with Cisplatin, 5-Fluorouracil, and Bevacizumab for Locally Advanced Resectable Esophageal Cancer

Efraim Idelevich; Hanoch Kashtan; Yoram Klein; Victor Buevich; Noa Ben Baruch; Michael Dinerman; Margarita Tokar; Yulia Kundel; Baruch Brenner

doi:10.1159/000340072

Prospective Phase II Study of Neoadjuvant Therapy with Cisplatin, 5-Fluorouracil, and Bevacizumab for Locally Advanced Resectable Esophageal Cancer

Onkologie ◽

10.1159/000340072 ◽

2012 ◽

Vol 35 (7-8) ◽

pp. 427-431 ◽

Cited By ~ 17

Author(s):

Efraim Idelevich ◽

Hanoch Kashtan ◽

Yoram Klein ◽

Victor Buevich ◽

Noa Ben Baruch ◽

...

Keyword(s):

Esophageal Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer ◽

Prospective Phase

Download Full-text

144P Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer (TD-NICE): A single arm, phase II study

Annals of Oncology ◽

10.1016/j.annonc.2021.10.163 ◽

2021 ◽

Vol 32 ◽

pp. S1442

Author(s):

X. Yan ◽

J. Zhao ◽

J. Lei ◽

H. Duan ◽

Y. Ni ◽

...

Keyword(s):

Esophageal Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

A phase II study to assess the efficacy of combined preoperative irinotecan (I)/cisplatin (C) chemotherapy and conformal radiotherapy (RT) followed by surgery for potentially resectable esophageal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4063 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4063-4063

Author(s):

J. J. Knox ◽

G. Darling ◽

M. Guindi ◽

S. Keshavjee ◽

E. X. Chen ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Conformal Radiotherapy ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

A phase II study of cisplatin, 5 fluorouracil (5-FU), radiation (RT) and celecoxib in patients with resectable esophageal cancer (EC): Updated results from the Hoosier Oncology Group (HOG) study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4052 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4052-4052 ◽

Cited By ~ 2

Author(s):

R. Govindan ◽

N. Fineberg ◽

H. McLeod ◽

K. Kesler ◽

N. Hanna ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

A phase II study of cisplatin, 5 fluorouracil (5-FU), radiation (RT) and celecoxib in patients with resectable esophageal cancer (EC): Updated results from the Hoosier Oncology Group (HOG) study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4052 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4052-4052 ◽

Cited By ~ 1

Author(s):

R. Govindan ◽

N. Fineberg ◽

H. McLeod ◽

K. Kesler ◽

N. Hanna ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

A phase II study of irinotecan and docetaxel with concurrent radiotherapy as preoperative treatment in resectable esophageal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4245 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4245-4245

Author(s):

J. A. Posey ◽

J. Thornton ◽

S. Russo ◽

R. Cerfolio ◽

M. Heslin ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Preoperative Treatment ◽

Concurrent Radiotherapy ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

A phase II study of irinotecan and docetaxel with concurrent radiotherapy as preoperative treatment in resectable esophageal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4245 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4245-4245

Author(s):

J. A. Posey ◽

J. Thornton ◽

S. Russo ◽

R. Cerfolio ◽

M. Heslin ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Preoperative Treatment ◽

Concurrent Radiotherapy ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

Randomized Phase II Study of Preoperative Concurrent chemoradiotherapy with or without Induction Chemotherapy with S-1 and Oxaliplatin in Patients with Resectable Esophageal Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)32046-9 ◽

2012 ◽

Vol 23 ◽

pp. xi45-xi46

Author(s):

D.H. Yoon ◽

G. Jang ◽

J.H. Kim ◽

Y.-H. Kim ◽

S. Son ◽

...

Keyword(s):

Esophageal Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

A phase II study to assess the efficacy of combined preoperative irinotecan (I)/cisplatin (C) chemotherapy and conformal radiotherapy (RT) followed by surgery for potentially resectable esophageal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4063 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4063-4063 ◽

Cited By ~ 2

Author(s):

J. J. Knox ◽

G. Darling ◽

M. Guindi ◽

S. Keshavjee ◽

E. X. Chen ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Conformal Radiotherapy ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer

Journal of Laparoendoscopic & Advanced Surgical Techniques ◽

10.1089/lap.2017.0320 ◽

2017 ◽

Vol 27 (12) ◽

pp. 1279-1283 ◽

Cited By ~ 5

Author(s):

Brian G.A. Dalton ◽

Adam J. Friedant ◽

Stacey Su ◽

Tiffany A.P. Schatz ◽

Karen J. Ruth ◽

...

Keyword(s):

Esophageal Cancer ◽

Neoadjuvant Therapy ◽

Locally Advanced ◽

Tube Feeding ◽

Jejunostomy Tube ◽

Resectable Esophageal ◽

Resectable Esophageal Cancer

Download Full-text

Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy

International Journal of Clinical Oncology ◽

10.1007/s10147-003-0344-6 ◽

2003 ◽

Vol 8 (5) ◽

pp. 305-311 ◽

Cited By ~ 11

Author(s):

Hiroaki Iwase ◽

Masaaki Shimada ◽

Motonori Nakamura ◽

Keiko Nakarai ◽

Takasi Iyo ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Study ◽

Locally Advanced ◽

Longterm Results

Download Full-text